Targeting N17 domain as a potential therapeutic target for the treatment of Huntington disease: An opinion

Authors

  • Vishal Kumar Department of Pharmacology, ISF College of Pharmacy, Moga-142001, Punjab, India; Affiliated to IK Gujral Punjab Technical University, Jalandhar, Punjab-144603, India https://orcid.org/0000-0003-3615-9374
  • Arti Singh Department of Pharmacology, ISF College of Pharmacy, Moga-142001, Punjab, India; Affiliated to IK Gujral Punjab Technical University, Jalandhar, Punjab-144603, India; E-mail: artiniper@gmail.com https://orcid.org/0000-0001-5168-4930

DOI:

https://doi.org/10.17179/excli2021-3670

Keywords:

Huntington disease, N17 domain, Reactive oxygen species (ROS)

Published

2021-06-09

How to Cite

Kumar, V. ., & Singh, A. (2021). Targeting N17 domain as a potential therapeutic target for the treatment of Huntington disease: An opinion. EXCLI Journal, 20, 1086–1090. https://doi.org/10.17179/excli2021-3670

Issue

Section

Letters to the editor